Ildong Holdings Co., Ltd (000230) AI Stock Analysis

Ildong Holdings Co., Ltd

(Korea Exchange:000230)

Select Model

Rating:59Neutral

Price Target:KRW 5,925.00▲(4.68% Upside)

Action:initiatedcoverage

Date:10/28/26

The score is supported primarily by very cheap valuation (low P/E and a dividend) and an improving financial trajectory as profitability and cash flow have turned positive. These positives are tempered by still-elevated leverage and bearish technical signals (below key moving averages with negative MACD), which add risk and limit the overall score.

Positive Factors

Profitability TurnaroundThe return to positive operating profit and net income indicates a meaningful recovery from the deep losses of 2021–2023. Healthy gross margin and improved cost control provide a foundation for rebuilding earnings, although continued execution is needed to make the improvement durable.

Negative Factors

Elevated LeverageDebt remaining above equity limits financial flexibility and can constrain how aggressively the group funds growth or supports subsidiaries. The prior leverage spike also demonstrates that the balance sheet has experienced meaningful stress, making deleveraging important for a more durable recovery.

Ildong Holdings Co., Ltd (000230) vs. SPDR S&P 500 ETF (SPY)

Market Cap: KRW 65.32B
Dividend Yield: 1.77%
Average Volume (3M): 24.69K
Price to Earnings (P/E): 2.1
Beta (1Y): 0.04
Revenue Growth: -3.85%
EPS Growth: -63.01%
Country: KR
Employees: 80
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

Ildong Holdings Co., Ltd Business Overview & Revenue Model

Company Description

Ildong Holdings Co., Ltd., established in Seoul, South Korea, in 1941, operates internationally, specializing in the innovation, production, and supply of pharmaceutical goods. The company actively researches and develops novel therapeutics for chall...

Ildong Holdings Co., Ltd Financial Statement Overview

Summary

Turnaround is evident with TTM profitability and cash flow back to positive, supported by healthy gross margin (~38%) and positive operating margin (~4.1%). However, leverage remains a key overhang (debt-to-equity ~1.13 TTM) and revenue/margin consistency is still volatile, so the financial profile is improving but not yet fully stabilized.

Income Statement

62Positive

Balance Sheet

48Neutral

Cash Flow

57Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	607.20B	590.89B	657.57B	638.45B	675.54B	592.37B
Gross Profit	229.51B	215.14B	232.79B	198.89B	239.13B	220.83B
EBITDA	53.20B	41.49B	124.42B	-64.04B	-116.29B	-41.66B
Net Income	21.66B	10.93B	63.04B	-59.59B	-102.35B	-70.89B
Balance Sheet
Total Assets	790.85B	802.86B	854.70B	877.00B	862.55B	920.76B
Cash, Cash Equivalents and Short-Term Investments	80.45B	77.81B	94.57B	102.48B	136.41B	200.84B
Total Debt	196.55B	217.02B	324.83B	325.36B	299.09B	324.09B
Total Liabilities	434.34B	457.28B	600.70B	707.10B	693.45B	737.42B
Stockholders Equity	173.87B	168.76B	133.89B	38.96B	11.81B	53.33B
Cash Flow
Free Cash Flow	26.30B	12.83B	1.72B	-77.26B	-95.73B	-53.28B
Operating Cash Flow	37.64B	26.86B	17.31B	-57.77B	-74.59B	-30.54B
Investing Cash Flow	19.67B	31.26B	22.45B	-16.34B	-32.50B	-48.87B
Financing Cash Flow	-61.25B	-60.71B	-32.00B	46.34B	31.65B	128.09B

Ildong Holdings Co., Ltd Technical Analysis

Technical Analysis SentimentNegative

Last Price5660.00

Price Trends

50DMA6123.60Negative

100DMA6243.30Negative

200DMA8348.76Negative

Market Momentum

MACD-112.79Positive

RSI34.76Neutral

STOCH24.69Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:000230, the sentiment is Negative. The current price of 5660.00 is below the 20-day moving average (MA) of 5978.50, below the 50-day MA of 6123.60, and below the 200-day MA of 8348.76, indicating a bearish trend. The MACD of -112.79 indicates Positive momentum. The RSI at 34.76 is Neutral, neither overbought nor oversold. The STOCH value of 24.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:000230.

Ildong Holdings Co., Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

KR:000230 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KR:096760	72Outperform	KRW 274.34B	3.25	―	5.42%	10.18%	149.93%
KR:000640	61Neutral	KRW 576.52B	6.95	―	1.96%	10.06%	-3.74%
KR:249420	60Neutral	KRW 397.78B	8.87	―	1.59%	-0.65%	―
KR:001630	59Neutral	KRW 169.48B	2.61	―	3.93%	1.43%	106.56%
KR:000230	59Neutral	KRW 63.91B	2.13	―	1.77%	-3.85%	-63.01%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
KR:002620	51Neutral	KRW 103.16B	12.22	―	1.04%	-15.55%	―

* General Sector Average

Performance Comparison

KR:000230 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
KR:000230	Ildong Holdings Co., Ltd	5660.00	-3304.30	-36.86%
KR:000640	Dong-A Socio Holdings Co., Ltd.	86900.00	-16225.73	-15.73%
KR:001630	Chong Kun Dang Holdings Co., Ltd.	35600.00	-7796.04	-17.96%
KR:002620	JEIL PHARMA HOLDINGS INC.	6720.00	-1121.77	-14.31%
KR:096760	JW Holdings Corporation	3965.00	856.99	27.57%
KR:249420	Ildong Pharmaceutical Co., Ltd.	12580.00	-14837.52	-54.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026

Ildong Holdings Co., Ltd AI Stock Analysis